Preparation of citalopram comprises the steps of: (a) converting the compound of Formula (I) to a compound of Formula (II), wherein R in Formula (I) represents a C2 to C5 alkylene group which may be substituted or unsubstituted, and R1 in the compounds of Formula (II) represents a carboxylic acid group or a salt or an ester thereof; and (b) converting the compound of Formula (II) to form citalopram or a pharmaceutically acceptable salt thereof, or a direct conversion of the compound of Formula (I) to citalopram ##STR1##

 
Web www.patentalert.com

< Use of Galectin-3 to promote the re-epithelialization of wounds

< OBG3 globular head and uses thereof for decreasing body mass

> Mixed amylin activity compounds

> Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity

~ 00240